RAPA-501 Autologous T stem cells — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-01 in 9d
ESTIMATED |
READOUT
RAPA-501 Therapy for ALS
Phase 2/3 · Amyotrophic Lateral Sclerosis |
Rapa Therapeutics LLC | RAPA-501 Autologous T stem cells |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|